Moderna takes its Covid-19 vaccine to the FDA

Moderna takes its Covid-19 vaccine to the FDA

Source: 
EP Vantage
snippet: 

The full results are in, and Moderna’s Covid-19 vaccine candidate, mRNA-1273, is on its way to regulators after showing efficacy of 94.1% in its pivotal trial. The final data from the Cove study are in line with the 94.5% shown at the interim analysis, and the 95% reported for Pfizer/Biotech’s rival, BNT162b2.